Cargando…
OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
In clinical studies, OM-85 Broncho-Vaxom(®), a bacterial lysate, reduced viral respiratory tract infection. Infection of epithelial cells by SARS-CoV-2 depends on the interaction of its spike-protein (S-protein) with host cell membrane proteins. In this study, we investigated the effect of OM-85 on...
Autores principales: | Fang, Lei, Zhou, Liang, Tamm, Michael, Roth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615539/ https://www.ncbi.nlm.nih.gov/pubmed/34829773 http://dx.doi.org/10.3390/biomedicines9111544 |
Ejemplares similares
-
Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023) -
Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP
por: Roth, Michael, et al.
Publicado: (2017) -
The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
por: Pivniouk, Vadim, et al.
Publicado: (2023) -
The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022) -
Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)